Global Innovative Traditional Chinese Medicine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Innovative Traditional Chinese Medicine Market Research Report 2024
Chinese medicine innovative drug refers to a new type of medicine developed through innovative research and development based on traditional Chinese medicine or Chinese herbal formulations. It may contain not only the traditional Chinese medicine ingredients, but also synthetic chemical compounds or natural substances, as well as processed and extracted Chinese medicine ingredients. The research and development of Chinese medicine innovative drugs follows the standards and procedures of modern drug development, using modern scientific techniques to screen, extract, and isolate the ingredients of Chinese herbal formulations in order to achieve more significant therapeutic effects, fewer side effects, and better absorption and utilization by the human body. The development of these drugs plays an important role in promoting the modernization and internationalization of traditional Chinese medicine.
According to Mr Accuracy reports’s new survey, global Innovative Traditional Chinese Medicine market is projected to reach US$ 2518.5 million in 2034, increasing from US$ 1781 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Innovative Traditional Chinese Medicine market research.
Key companies engaged in the Innovative Traditional Chinese Medicine industry include Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly, Yangtze River Pharmaceutical, Hutchison, ApicHope, Jiangzhong Pharmaceutical, Buchang Pharma and Guizhou Bailing, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Innovative Traditional Chinese Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Innovative Traditional Chinese Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Innovative Traditional Chinese Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Yiling Pharmaceutical
Kanion Pharmaceutical
Tasly
Yangtze River Pharmaceutical
Hutchison
ApicHope
Jiangzhong Pharmaceutical
Buchang Pharma
Guizhou Bailing
Zhangzhou Pien Tze Huang Pharmaceutical
Jumpcan Pharmaceutical
Xiangxue Pharma
KPC Pharmaceutical
CONSUN
Huluwa Pharmaceutical
Fangsheng Pharma
BaiYunShan
Segment by Type
Drug Capsules
Pharmaceutical Granules
Medicine Tablet
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Innovative Traditional Chinese Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Innovative Traditional Chinese Medicine market is projected to reach US$ 2518.5 million in 2034, increasing from US$ 1781 million in 2022, with the CAGR of 5.2% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Innovative Traditional Chinese Medicine market research.
Key companies engaged in the Innovative Traditional Chinese Medicine industry include Yiling Pharmaceutical, Kanion Pharmaceutical, Tasly, Yangtze River Pharmaceutical, Hutchison, ApicHope, Jiangzhong Pharmaceutical, Buchang Pharma and Guizhou Bailing, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Innovative Traditional Chinese Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Innovative Traditional Chinese Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Innovative Traditional Chinese Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Yiling Pharmaceutical
Kanion Pharmaceutical
Tasly
Yangtze River Pharmaceutical
Hutchison
ApicHope
Jiangzhong Pharmaceutical
Buchang Pharma
Guizhou Bailing
Zhangzhou Pien Tze Huang Pharmaceutical
Jumpcan Pharmaceutical
Xiangxue Pharma
KPC Pharmaceutical
CONSUN
Huluwa Pharmaceutical
Fangsheng Pharma
BaiYunShan
Segment by Type
Drug Capsules
Pharmaceutical Granules
Medicine Tablet
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Innovative Traditional Chinese Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices